Case Report: Oral lichenoid mucositis in a patient with metastatic renal cell carcinoma undergoing treatment with pembrolizumab and axitinib
Stomatitis is a relatively common adverse effect of systemic pharmacologic therapy seen in the treatment of various malignancies. When severe, stomatitis has the potential to limit a patient’s ability to tolerate optimal medical therapy and to impact quality of life. There are a variety of etiologie...
Saved in:
| Main Authors: | Andrew Wellen, Michael J. Pierro, Karolyn A. Wanat, Ariel A. Nelson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1495446/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Delayed lichenoid drug eruption associated with apremilast
by: Betty Hinderks-Davis, MD, et al.
Published: (2025-05-01) -
Successful Treatment of Ustekinumab-Associated Lichenoid Drug Eruption with Upadacitinib: A Case Report
by: Xia M, et al.
Published: (2025-04-01) -
Study on the potential links between clinical features of oral lichenoid mucositis and systemic diseases
by: Peilin Wang, et al.
Published: (2025-04-01) -
Pityriasis lichenoides et varioliformis acuta in a patient on zanubrutinib for marginal zone lymphoma
by: Aliya Rogers, MD, et al.
Published: (2025-01-01) -
Prostate-specific membrane antigen (PSMA) expression in primary and metastatic renal cell cancer (UroCCR-65 study)
by: Salma Binzaqr, et al.
Published: (2025-04-01)